Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis(RA) is characterized by the presence of arelative state of imbalance between pro- and anti-inflammatorycytokines such as Interleukin(IL)17 and IL4, respectively. IL4 issupposed to regulate production of IL17 from T-helper (Th)17 cells.However, this regulatory function might be affected bysinglenucleotide polymorphism (SNP) of IL4 receptor (IL4R) gene,rs1805010. The current study aimed to assess serum IL17 level inEgyptian patients with RA according toIL4Rrs1805010 genotypes,andto detect possibleassociations betweenIL17/ IL4R genotypesandclinical status, disease activity as well as effect of treatment. SerumIL17 was assessed by ELISA, and qPCR was used to determine thegenotypes of IL4R SNP rs1805010. Serum IL17 was significantlyincreased in patients’ samples as compared to controls. According toIL4R genotypes, patients with AG and GG genotypes showedsignificantly higher IL17 levels than control subjects withcorresponding genotypes. Within RA group, significantly higher IL17were found in GG carriers compared to those with AA genotype. TheG allele was significantly associated with higherythrocytesedimentation rate(ESR), increased disease activity score in 28 joints (DAS28), highLarsen score and seropositive rheumatoid factor (RF)as well as C-reactive protein (CRP).Patients with AG and GGgenotypes demonstrated significant positive correlations between serum IL17 and DAS28. Meanwhile, serum IL17 levels and Larsen score had significant positive correlation only in GG patients.The use of different treatment regimens did not affect serum IL17 levels significantly in various genotypes. In conclusion, IL17 may beimplicated in the pathogenesis of RA, being associated with a higherdisease activity parameters, however, its action may be potentiateddue to loss of the functional IL4RA allele (rs1805010), particularly incarriers ofthe GG genotype. Furthermore, determining the geneticvariants of IL4R rs1805010 may be promising for identification ofpatients at risk worse prognosis.
No takes yet. Share an insight, caveat, or question.
Elnady et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: